We are live on ! Find out more
NGNE icon

Neurogene
NGNE

85 hedge funds and large institutions have $187M invested in Neurogene in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

230% more call options, than puts

Call options by funds: $287K | Put options by funds: $87K

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

4% more funds holding

Funds holding: 82 → 85 (+3)

0.14% less ownership

Funds ownership: 3.18% → 3.05% (-0.14%)

7% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 28

25% less capital invested

Capital invested by funds: $249M → $187M (-$61.5M)

Holders
85
Holders Change
+3
Holders Change %
+3.66%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
26
Reduced
28
Closed
8
Calls
$287K
Puts
$87K
Net Calls
+$200K
Net Calls Change
+$1.46M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$2.65M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.38M
3
Millennium Management
Millennium Management
New York
+$938K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$895K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$880K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$11.5M
2
State Street
State Street
Massachusetts
-$4.78M
3
RG
Redmile Group
California
-$3.15M
4
OM
Opaleye Management
Massachusetts
-$834K
5
Goldman Sachs
Goldman Sachs
New York
-$697K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$850K -$697K -4,553 -44%
JP Morgan Chase
27
JP Morgan Chase
New York
$688K +$603K +3,939 +485%
Charles Schwab
28
Charles Schwab
California
$641K – – –
GCP
29
GSA Capital Partners
United Kingdom
$545K +$577K +3,771 New
Swiss National Bank
30
Swiss National Bank
Switzerland
$534K – – –
HF
31
HRT Financial
New York
$382K +$405K +2,645 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$353K +$1.38K +9 +0.4%
HPWM
33
Highland Private Wealth Management
Washington
$340K – – –
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$328K -$39.2K -256 -10%
Los Angeles Capital Management
35
Los Angeles Capital Management
California
$308K -$28.5K -186 -8%
SCM
36
Sio Capital Management
New York
$277K – – –
TI
37
Trexquant Investment
Connecticut
$248K +$154K +1,004 +141%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$243K -$99.5K -650 -28%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$198K -$112K -734 -35%
AllianceBernstein
40
AllianceBernstein
Tennessee
$191K – – –
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$189K +$200K +1,308 New
PCS
42
Personal CFO Solutions
New Jersey
$179K +$7.66K +50 +4%
CGL
43
Clarius Group LLC
Washington
$171K +$612 +4 +0.3%
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$167K -$107K -700 -38%
SG Americas Securities
45
SG Americas Securities
New York
$162K +$171K +1,117 New
Citadel Advisors
46
Citadel Advisors
Florida
$161K +$90.3K +590 +112%
Deutsche Bank
47
Deutsche Bank
Germany
$157K -$5.05K -33 -3%
PP
48
PDT Partners
New York
$150K +$159K +1,039 New
Janney Montgomery Scott
49
Janney Montgomery Scott
Pennsylvania
$145K – – –
Marshall Wace
50
Marshall Wace
United Kingdom
$140K +$149K +971 New
1
2
3 4

NGNE Hedge Fund Activity: Q3 2021 in Review

85 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q3 2021, worth a combined $187M — down 25% from $249M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NGNE positions and 8 closed out — a net gain of 4 holders — while 26 added to existing stakes and 28 trimmed.

The largest buyer was Candriam SCA, adding an estimated $2.65M. The largest seller was EcoR1 Capital, cutting an estimated $11.5M.

  • 85 institutional investors held Neurogene (NGNE) as of Q3 2021, up from 82 in Q2 2021.
  • Funds reported $187M of Neurogene stock for Q3 2021, down 25% quarter-over-quarter.
  • 12 funds opened new Neurogene positions in Q3 2021 and 8 closed out, a net change of +4 holders.
  • The largest Neurogene buyer in Q3 2021 was Candriam SCA, an estimated $2.65M added.
  • The largest Neurogene seller in Q3 2021 was EcoR1 Capital, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2021.